Yahoo
ASX - Delayed Quote AUD

Adherium Limited (ADR.AX)

0.0670 0.0000 (0.00%)
At close: October 26 at 1:27:46 PM GMT+11
Chart Range Bar
Loading chart for ADR.AX
  • Previous Close 0.0670
  • Open 0.0630
  • Bid 0.0680 x --
  • Ask 0.0690 x --
  • Day's Range 0.0630 - 0.0670
  • 52 Week Range 0.0600 - 0.6720
  • Volume 72,078
  • Avg. Volume 24,099
  • Market Cap (intraday) 3.677M
  • Beta (5Y Monthly) 1.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 0.88

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use and improve health outcomes in chronic diseases. The company offers Hailie Smartinhaler, a cloud-based platform which captures medication use data from Bluetooth enabled sensors which wrap around patient inhalers and provide real-time feedback to patients; Hailie Smartinhaler Sensors, a device coverage that works for Rescuer/Reliever and Preventer inhalers; Hailie solution; and Hailie Remote Patient Monitoring (RPM) Solution. It operates in New Zealand, Australia, South East Asian Countries, and North America. Adherium Limited was founded in 2001 and is based in Melbourne, Australia.

www.adherium.com

--

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

ADR.AX
84.05%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

ADR.AX
82.28%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

ADR.AX
97.83%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

ADR.AX
99.54%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

0.88
0.88 Average
0.0670 Current
0.88 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -204.79%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.1M

  • Net Income Avi to Common (ttm)

    -14.16M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.42M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -10.07M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: